Codes / ICD10CM / L50.0

L50.0 Allergic urticaria

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Allergic urticaria

Summary

Allergic urticaria is a skin condition characterized by the sudden appearance of itchy, raised welts (hives) due to an allergic reaction. The reaction occurs when the immune system releases histamine in response to an allergen, causing blood vessels to leak fluid into the skin. Symptoms typically develop within minutes to hours of exposure and may resolve within hours or persist for days.

Causes

Allergic urticaria is triggered by an immune system response to specific allergens, such as foods (e.g., nuts, shellfish), medications (e.g., antibiotics, NSAIDs), insect stings, or environmental factors (e.g., pollen, pet dander). The reaction involves IgE antibodies binding to allergens, leading to mast cell activation and histamine release, which causes the characteristic skin changes.

Risk Factors

  • Previous allergic reactions or atopy (e.g., eczema, asthma).
  • Family history of allergies or urticaria.
  • Exposure to known allergens (e.g., certain foods, medications).
  • Underlying autoimmune conditions (e.g., lupus, thyroid disease).
  • Infections (e.g., viral or bacterial) that may trigger immune responses.

Symptoms

  • Itchy, raised red or skin-colored welts (hives) that vary in size and shape.
  • Swelling of the lips, tongue, or face (angioedema) in severe cases.
  • Welts that appear suddenly and may change location or disappear within hours.
  • Burning or stinging sensation in affected areas.

Diagnosis

Diagnosis is based on clinical evaluation of symptoms and a detailed patient history to identify potential triggers. Healthcare providers may inquire about recent exposures, medications, or dietary changes. In some cases, allergy testing (e.g., skin prick tests, blood tests) or elimination diets may be used to confirm specific allergens, though this is not always necessary for acute cases.

Treatment Options

  • Antihistamines: First-line treatment to reduce itching and swelling (e.g., cetirizine, loratadine).
  • Corticosteroids: Short-term use for severe or persistent symptoms (e.g., prednisone).
  • Epinephrine: Administered for anaphylactic reactions involving airway or circulatory compromise.
  • Avoidance of triggers: Identifying and eliminating known allergens to prevent recurrence.

Prognosis and Follow-Up

Most cases of allergic urticaria resolve within 24–48 hours with treatment. Chronic urticaria (lasting >6 weeks) may require ongoing management. Follow-up is recommended if symptoms persist, worsen, or recur frequently to assess for underlying causes or complications. Patients with severe reactions should carry an epinephrine auto-injector and seek immediate care for future episodes.

Complications

  • Anaphylaxis: A life-threatening systemic reaction involving airway obstruction, hypotension, or shock.
  • Angioedema: Severe swelling of the lips, tongue, or throat, potentially impairing breathing.
  • Chronic urticaria: Persistent symptoms lasting months or years, impacting quality of life.

Lifestyle & Prevention

  • Identify and avoid known allergens (e.g., specific foods, medications).
  • Read labels carefully for hidden allergens in foods or products.
  • Carry emergency medication (e.g., epinephrine) if prescribed.
  • Wear medical identification (e.g., bracelet) for severe allergies.
  • Maintain good hygiene to reduce infection-related triggers.

When to Seek Professional Help

Seek immediate medical attention if symptoms include:

  • Difficulty breathing, wheezing, or tightness in the chest.
  • Swelling of the face, lips, or tongue.
  • Dizziness, fainting, or rapid heartbeat.
  • Widespread or rapidly spreading hives.
  • Persistent symptoms lasting more than 48 hours despite treatment.

Tips for Medical Coders

Document the clinical presentation, including the presence of hives, angioedema, or anaphylaxis, to support the diagnosis. Note any identified triggers (e.g., food, medication) or comorbid allergic conditions. Ensure documentation aligns with the specific code L50.0 for allergic urticaria, distinguishing it from other urticaria subtypes (e.g., physical or idiopathic) when applicable.

Medical Policies and Guidelines

Related policies from health plans

Xolair (omalizumab)
Book a walkthrough

L50.0 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.